Article Information
vol. 7 no. 2
Published By
Online ISSN
History
- Received June 24, 2020
- Accepted November 14, 2020
- Published online April 19, 2021.
Article Versions
- previous version (December 17, 2020 - 09:28).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©ERS 2021 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Jutta Beier1⇑,
- Henrik Watz2,
- Zuzana Diamant3,4,5,
- Jens M. Hohlfeld6,7,8,
- Dave Singh9,
- Pascale Pinot10,
- Ieuan Jones11 and
- Hanns-Christian Tillmann10
- 1Insaf Respiratory Research Institute, Wiesbaden, Germany
- 2Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany
- 3Dept of Respiratory Medicine and Allergology, Institute for Clinical Science, Skåne University Hospital, Lund, Sweden
- 4Dept of Microbiology, Immunology and Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium
- 5Dept of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre and QPS-NL, Groningen, The Netherlands
- 6German Center for Lung Research (BREATH), Hannover, Germany
- 7Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany
- 8Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany
- 9University of Manchester, Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester, UK
- 10Novartis Institutes for Biomedical Research, Basel, Switzerland
- 11Novartis Pharma AG, Basel, Switzerland
- Jutta Beier, Insaf Respiratory Research Institute, Biebricher Allee 34, 65187 Wiesbaden, Germany. E-mail: j.beier{at}insaf-wi.de
Funding
Novartis Pharma
QVM149B2209
Article usage
Altmetrics
Vol 7 Issue 2
Table of Contents
Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial
